United States · Series B startup
3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$79Mraised across 3 rounds since 2005, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by fis.dowjones.comSEC filing: $36M sold, first sale Jan 2008
Reported by taligentherapeutics.com
Sanderling VenturesReported by taligentherapeutics.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Sanderling VenturesHigh Country Venture
Alta Partners
Clarus VenturesUniversity License Equity HoldingsFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Taligen Therapeutics's investors include Sanderling Ventures, High Country Venture, Alta Partners, Clarus Ventures and University License Equity Holdings.
Taligen Therapeutics has raised $79M across 3 rounds since 2005.
Taligen Therapeutics's most recent round was a Series B of $10M in Aug 2010.
Taligen Therapeutics's largest round on record is $65M (Series B), in Jan 2008.
Taligen Therapeutics's first round on record, in Aug 2005, was backed by Sanderling Ventures, High Country Venture and University License Equity Holdings.
Taligen Therapeutics's latest named round is a Series B, in Aug 2010.
Taligen Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·